An anonymous reader writes: An HIV/AIDS vaccine developed in Ontario has applied for Phase 1 human trials. Safety and immunogenicity studies of the vaccine, dubbed SAV001-H, have already been completed on animals. Phase 1 human trials will check the safety of the vaccine on HIV positive volunteers. Phase 2 will then test immunogenicity.
Sign up for the Slashdot Daily Newsletter! DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Win a FREE Moto Z2 Force Edition smartphone from Wirefly ×